Feeding Trial in the Obese Critical Care Population

Sponsor
Nestlé (Industry)
Overall Status
Completed
CT.gov ID
NCT01357200
Collaborator
(none)
26
2
31
13
0.4

Study Details

Study Description

Brief Summary

This study will assess enteral feeding in an obese critically ill population with a higher protein whey based peptide formula.

Condition or Disease Intervention/Treatment Phase
  • Other: enteral formula

Detailed Description

Assess enteral feeding goal with a higher protein whey based peptide formula in an obese critically ill population.

Study Design

Study Type:
Observational
Actual Enrollment :
26 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Enteral Formula Tolerance in the Obese Critical Care Population
Study Start Date :
May 1, 2011
Actual Primary Completion Date :
Dec 1, 2013
Actual Study Completion Date :
Dec 1, 2013

Arms and Interventions

Arm Intervention/Treatment
critically ill obese adults

Age ≥ 18 years, body mass index (BMI) ≥ 30, in intensive care unit (ICU) requiring tube feeding ≥ 3 days

Other: enteral formula
Complete feeding of study enteral formula, route and regime prescribed by the physician.

Outcome Measures

Primary Outcome Measures

  1. time to feeding goal achievement [up to 5 days]

    on all participants

Secondary Outcome Measures

  1. gastrointestinal measures assessment [daily for up to 11 days]

    on all participants

  2. percent of nutrition goal met [up to 5 days]

    on all participants

  3. serum biochemical markers assessment [daily for up to 11 days]

    on all participants

  4. assessment of frequency and nature of adverse events [daily for up to 11 days]

    on all participants

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age ≥ 18 years

  • Surgical or Medical intensive care unit (ICU) patient

  • Body mass index (BMI) ≥ 30

Exclusion Criteria:
  • pregnant or lactating

  • unable to access gastrointestinal (GI) tract for feeding via tube

  • other contraindication to tube feeding

  • admitted with burns

  • severe head trauma

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Kentucky Lexington Kentucky United States 40536
2 University of Louisville Louisville Kentucky United States 40202

Sponsors and Collaborators

  • Nestlé

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Nestlé
ClinicalTrials.gov Identifier:
NCT01357200
Other Study ID Numbers:
  • 10.02.US.CLI
First Posted:
May 20, 2011
Last Update Posted:
Jan 30, 2014
Last Verified:
Jan 1, 2014
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 30, 2014